SHEILA OPPENHEIMER: Open Payments
NPI 1841488186 · MILFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$819 in 7 payments from 5 companies in 2025. Trend: 2023 $1,082 · 2024 $1,117 · 2025 $819
Food & beverage: $819
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $338 |
| Axsome Therapeutics, Inc. | 1 | $125 |
| ABBVIE INC. | 1 | $125 |
| Lilly USA, LLC | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 1 | $106 |
Products named: CAPLYTA, Auvelity, VRAYLAR, KISUNLA, UZEDY.
Industry payments across CT — which companies pay providers there.
